Digital Lifestyle Intervention for Lung Cancer Survivors
Recruiting
N/A
Interventional Study
Non-Small Cell Lung Cancer (NSCLC)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 88 (estimated)
- Sponsor
- Kai-Uwe Schmitt, PhD, MEng, ICID · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of this study is to assess the efficacy of a digital lifestyle intervention in non-small cell lung cancer (NSCLC) survivors on health-related quality of life (HRQoL) over three months.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 years
* Diagnosis of non-small cell lung cancer (NSCLC)
* Estimated life expectancy of ≥ six months (judged by local investigators/responsible health professionals)
* Undergoing inpatient or outpatient rehabilitation OR completion of planned surgery, chemotherapy, or …
Contacts